THE FITEC STUDY: Free Iron release during chemotherapy in Testicular Cancer Patients

THE FITEC STUDY: Free Iron release during chemotherapy in Testicular Cancer Patients - FITEC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31217

Enrollment

Registered

2007-08-13

Start date

2007-06-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

germ cell malignancy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adults willing and able to give written informed consent in case of patients: those who are scheduled to undergo chemotherapy for testicular cancer.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
1.Concentrations of free iron, i.e. non protein bound iron (NPBI), ferritin, transferritin and latent iron binding capacity (LIBC)	—

Secondary

Measure	Time frame
2.Vascular parameters 3.Lipid profile and gonadal and gonadotrophin hormone concentrations (these are routinely assessed) 4.hepatic triglyceride content 5.Assessment of immune responses pre- and post-chemotherapy against testis antigens	—

Countries

Netherlands

Outcome results